ArticleActive
Response to Comments: Immune Globulin Intravenous (IVIg)
A54645
Effective: November 7, 2015
Updated: December 31, 2025
Policy Summary
The supplied content includes only the policy header for Noridian's response to comments on Intravenous Immune Globulin (IVIg) (Policy ID A54645) and contains no substantive coverage criteria. Indications, limitations, documentation requirements, and frequency limits cannot be extracted from the provided text; obtain the full policy document for complete extraction.
Coverage Criteria Preview
Key requirements from the full policy
"Policy text not provided in input; full Noridian response to comments for IVIg unavailable—manual review of the complete policy document is required to extract required documentation and coverage c..."
Sign up to see full coverage criteria, indications, and limitations.